Objective. To measure, and seek clinical correlates with, levels of substance P (SP) in the cerebrospinal fluid (CSF) of fibromyalgia syndrome (FMS) patients. Methods. CSF from 32 FMS patients and 30 normal control subjects was tested for SP by radioimmunoassay . Clinical measures included tender p
Huntington's chorea—Measurements of somatostatin, substance P and Cyclic nucleotides in the cerebrospinal fluid
✍ Scribed by H. Cramer; J. Kohler; G. Oepen; G. Schomburg; E. Schröter
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 303 KB
- Volume
- 225
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
✦ Synopsis
Somatostatin, substance P, cyclic AMP and cyclic GMP were determined in the cerebrospinal fluid of patients with Huntington's disease, in first generation relatives of choreic patients and in neurological control patients. Substance P levels were not significantly altered, but somatostatin levels were markedly decreased both in affected patients and symptom-free offspring. Cyclic AMP was decreased only in patients with advanced stages of the disease while cyclic GMP was normal. Evidence is discussed which may support a role of somatostatin deficiency in the pathophysiology of chorea.
📜 SIMILAR VOLUMES
A total of 27 different amino acids were determined in the fasting, morning lumbar CSF of 12 patients with Huntington's Disease (HD), 8 at-risk offspring and 16 non-choreic control patients. A significant (P less than 0.001) decrease was observed for asparagine, isoleucine, leucine, phenylalanine, h